Drug Shortage Report for ANORO ELLIPTA

Last updated on 2019-02-08 History
Report ID 73358
Drug Identification Number 02418401
Brand name ANORO ELLIPTA
Common or Proper name umeclidinium (as bromide) and vilanterol (as trifenatate) dry powder for oral inhalation
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) Vilanterol Umeclidinium
Strength(s) 25MCG 62.5MCG
Dosage form(s) POWDER
Route of administration INHALATION
Packaging size 1x7
ATC code R03AL
ATC description ADRENERGICS, INHALANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-01-18
Estimated end date 2019-02-15
Actual end date 2019-02-07
Shortage status Resolved
Updated date 2019-02-08
Company comments 30 dose format is available.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-01-23 English Compare
v2 2019-01-23 French Compare
v3 2019-02-08 English Compare

Showing 1 to 3 of 3